SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-19-000401
Filing Date
2019-02-14
Accepted
2019-02-14 17:13:26
Documents
51
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT sonoma_10q-123118.htm 10-Q 364913
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER sonoma_10q-ex3101.htm EX-31.1 8425
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER sonoma_10q-ex3102.htm EX-31.2 8432
4 CERTIFICATION sonoma_10q-ex3201.htm EX-32.1 3528
  Complete submission text file 0001683168-19-000401.txt   2340671

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE snoa-20181231.xml EX-101.INS 366211
6 XBRL SCHEMA FILE snoa-20181231.xsd EX-101.SCH 24770
7 XBRL CALCULATION FILE snoa-20181231_cal.xml EX-101.CAL 44184
8 XBRL DEFINITION FILE snoa-20181231_def.xml EX-101.DEF 99829
9 XBRL LABEL FILE snoa-20181231_lab.xml EX-101.LAB 211215
10 XBRL PRESENTATION FILE snoa-20181231_pre.xml EX-101.PRE 181917
Mailing Address 1129 N. MCDOWELL BLVD. PETALUMA CA 94954
Business Address 1129 N. MCDOWELL BLVD. PETALUMA CA 94954 707-283-0550
Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)

IRS No.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-33216 | Film No.: 19608195
SIC: 2834 Pharmaceutical Preparations